independent pharmacy channel, totaling approximately 4.99 million baht which increased by 2.24 million baht year-on-year due to increased sales. Some expenses have dropped i. e. sales promotion expenses, booth
processing period until the applicant has corrected the application or submitted additional documents fully according to the record of defect. (Unofficial Translation) 2 Service Channel Location: The
Financial Reporting Standard (IFRS). The significant changes are summarized as follows: 2.1 TFRS 9 Financial Instruments The Company reclassified of financial assets and financial liabilities to be consistent
slower rate consistent with economic slowdown. Personal loans still expanded. Meanwhile, loans to business contracted. Commercial banks were tighter in extending loans in line with economic conditions as
Instruments The Company reclassified of financial assets and financial liabilities to be consistent with the business model and management of the company’s assets and liabilities, based on the facts and
consistent with the Company’s capital increase, details are as follows: “Clause 4 Registered Capital THB 970,283,450 (Nine Hundred Seventy Million Two Hundred Eighty Three Thousand Four Hundred Fifty Baht
amendment of Number 4. of the Company’s Memorandum of Association, to be in consistent with the Company’s capital increase, details are as follows: “Clause 4 Registered Capital THB 970,283,450 (Nine Hundred
propose to the Shareholders’ Meeting to consider to approve an amendment of Number 4. of the Company’s Memorandum of Association, to be in consistent with the Company’s capital increase, details are as
hospitality business, which was consistent with incremental revenue. Administrative Expenses Administrative expenses mainly comprise of back office personnel expenses, depreciation on assets under hospitality
expenses amounted to THB 1,526m, an increase of 56% YoY. This was due primarily to an increase of advertisement expenses related to both residential business and hospitality business, which was consistent